None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 19 years and above scheduled for gynecological surgery under general anesthesia using laparoscopy as a regular surgical procedure. 2. Patients with American Society of Anesthesiologists (ASA) physical status classification 1-3. 3. Patients who have voluntarily provided written consent to participate in this clinical research study.
Exclusion criteria
Exclusion criteria: Patients with severe blood disorders, severe liver dysfunction, severe kidney dysfunction, severe congestive heart failure, or severe hypertension. Patients with a history of hypersensitivity or allergic reactions, such as asthma, urticaria, or allergies, to aspirin or other NSAIDs. Patients with a history of bronchial asthma or its equivalent. Patients with a history of gastrointestinal ulcers, gastrointestinal bleeding, or their equivalents. Pregnant women. Patients with physical disabilities or illiteracy. Other patients deemed unsuitable by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The total QoR-15K score at 1 day after surgery;The total QoR-15K score at 2 day after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| The total amount of Fentanyl used during the first day after surgery;The average NRS (Numeric Rating Scale) score during the first day after surgery;The average PONV (Postoperative Nausea and Vomiting) score during the first day after surgery;The total amount of Fentanyl used during the second day after surgery;The average NRS (Numeric Rating Scale) score during the second day after surgery;The average PONV (Postoperative Nausea and Vomiting) score during the second day after surgery;The amount of remifentanil used during surgery;Post-anesthesia care unit admission time and total length of stay | — |
Countries
Korea, Republic of
Contacts
Chonnam National University Hospital